VIMPAT (lacosamide) for the Treatment of Primary Generalised Tonic-Clonic Seizures (PGTCS)

Image 1- Vimpat (Lacosamide)
VIMPAT is indicated as an adjunctive therapy for the treatment of primary generalised tonic-clonic seizures (PGTCS) in patients aged four years and above. Credit: StudioMolekuul/Shutterstock.